The relationship between polysubstance abuse and myocardial histopathological lesions

Đỗ Thị Thương Thương Đỗ Thị Thương Thương

doi:10.59294/HIUJS.VOL.6.2024.624

Từ khóa:

lạm dụng thuốc, lạm dụng đa chất, tổn thương cơ tim

Abstract

Background: Substance abuse can affect most organs of the body, with the cardiovascular system being a primary target. Objective: This study aims to investigate the association between myocardial lesions and polysubstance use status. Subjects and Methods: Subjects and Methods: A total of fifty-five deceased individuals were examined at the Ho Chi Minh City Forensic Medicine Center, all of whom tested positive for substance abuse through blood tests. Myocardial injuries were assessed using Hematoxylin and Eosin (HE) and Trichrome Masson histopathology specimens. Results: The study found that all cases (100%) involved morphine use, with 65.5% involving the concurrent use of two substances and 7.3% involving the concurrent use of three substances. The most common myocardial lesions observed were fibrotic proliferation (72.7%) and ischemia-related lesions (34.5%). Conclusion: The study demonstrates a significant association between polysubstance abuse and the risk of fibrogenesis and fat infiltration in the myocardium. These findings underscore the importance of addressing polysubstance abuse in cardiovascular health interventions.

Tài liệu tham khảo

[1] World Health Organization, ed. WHO Expert Committee on Drug Dependence: sixteenth report. Geneva: WHO Press, 1969.

[2] Drummer OH, Karch SB. Karch's Pathology of Drug Abuse, New York, CRC Press, 2016.

[3] Seltenhammer MH, Marchart K, Paula P, et al., “Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse: Chronic opioid abuse triggers heart fibrosis”, Addiction, 108(7), 1287–1295, 2013.

DOI: https://doi.org/10.1111/add.12106

[4] Milroy CM, Parai JL, “The histopathology of drugs of abuse: Histopathology of drugs of abuse,” Histopathology, 59(4), 579–593, 2011.

DOI: https://doi.org/10.1111/j.1365-2559.2010.03728.x

[5] Dettmeyer R, Friedrich K, Schmidt P, et al., “Heroin-associated myocardial damages- Conventional and immunohistochemical investigations”, Forensic Sci Int,187(1–3), 42–46, 2009.

DOI: https://doi.org/10.1016/j.forsciint.2009.02.014

[6] Taylor A, Frisher M, Goldberg D., “Non-fatal overdosing is related to polydrug use in Glasgow,” BMJ., 313, 1400-1401, 1996.

DOI: https://doi.org/10.1136/bmj.313.7069.1400b

[7] Ochoa KC, Hahn JA, Karen HS, et al., “Overdosing among young injection drug users in San Francisco”, Addict. Behav, 26, 453–460, 2001.

DOI: https://doi.org/10.1016/S0306-4603(00)00115-5

[8] Logan B, Fligner CL, Haddix T., “Cause and manner of death in fatalities involving methamphetamine”, J. Forensic. Sci., 43, 28–34, 1998.

DOI: https://doi.org/10.1520/JFS16085J

[9] United Nations Office on Drugs and Crimes, ed. World drug report 2018 II. Vienna: United Nations Publication; 2018.

[10] Matoba R., “Cardiac lesions in metham-phetamine abusers”, Nihon Hoigaku Zasshi, 55(3), 321-330, 2001.

[11] Dressler FA, Roberts WC., “Modes of death and types of cardiac diseases in opiate addicts: analysis of 168 necropsy cases,” Am. J. Cardiol., 64, 909–920, 1989.

DOI: https://doi.org/10.1016/0002-9149(89)90841-2

[12] Kong P, Frangolannls NG., “The pathogenesis of cardiac fibrosis”, Cell. Mol. Life Sci., 71(4), 549-574, 2013.

DOI: https://doi.org/10.1007/s00018-013-1349-6

[13] Passarino G, Ciccone G, Siragusa R, et al., “Histopathological Findings in 851 Autopsies of Drug Addicts, With Toxicologic and Virologic Correlations”, Am. J. Forensic Med. Pathol, 26(2), 106-116, 2005.

DOI: https://doi.org/10.1097/01.paf.0000159990.54730.4b

[14] Kumar V, Abbas AK, Aster JC, ed. Robbins and Cotran Pathologic Basis of Disease, Philadelphia: Elsevier/Saunders, 2015.

[15] Stringer J, Welsh C, Tommasello A., “Methadone-associated Q-T interval prolongation and torsades de pointes”, Am J Health Syst Pharm, 66(9), 825-833, 2009.

DOI: https://doi.org/10.2146/ajhp070392